Global Diabetes Drug Market Sales Revenue Clinical Trials Pipeline Report 2015

Diabetes market is a rapidly growing segment with numerous products at different stages of clinical pipeline and others at different phases of industry life cycle. Disease incidences are escalating rapidly across the globe due to which high unmet demand has been created and pharmaceutical companies are trying to provide efficient medical care to patients. Large patient base and superior technology are some important factors responsible for continuous growth of this market segment across the globe. Significant investments in research and development segment could also be attributed as the main reason behind its growth. As a result, several innovative products are under investigation which would be introduced in market after passing pre described clinical end points and criterias set by medical regulatory authorities. Number of diabetes drugs for treatment is increasing every year due to which their market shares are expected to increase further in coming years.

Download Report:

https://www.kuickresearch.com/report-Global-Diabetes-Drug-Market-&-Pipeline-Insight-2015.php

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

1. Introduction to Diabetes

2. Diabetes Drug Mechanism

3. Global Diabetes Drug Market Overview
3.1 Current Market Scenario
3.2 Global Diabetes Drug Pipeline Overview

4. Global Diabetes Drug Market Dynamics
4.1 Favorable Market Parameters
4.2 Development & Commercialization Challenges

5. Global Diabetes Drug Market Future Prospects

6. Diabetic Neuropathies Drug Clinical Pipeline by Company & Phase
6.1 Research to till Registered
6.2 Marketed Drug Clinical Insight

7. Diabetic Nephropathies Drug Clinical Pipeline by Company & Phase
7.1 Research to till Registered
7.2 Marketed Drug Clinical Insight

8. Diabetes Mellitus Drug Clinical Pipeline by Company & Phase
8.1 Phase Research to till Registered
8.2 Marketed Drug Clinical Insight

9. Type 1 Diabetes Mellitus Drug Clinical Pipeline by Company & Phase
9.1 Research to till Registered
9.2 Marketed Drug Clinical Insight

10. Type 2 Diabetes Mellitus Drug Clinical Pipeline by Company & Phase
10.1 Research to till Registered
10.2 Marketed Drug Clinical Insight

11. Diabetic Foot Ulcer Drug Clinical Pipeline by Company & Phase
11.1 Research to till Phase-III
11.2 Marketed Drug Clinical Insight

12. Diabetic Macular Oedema Drug Clinical Pipeline by Company & Phase
12.1 Research to till Registered
12.2 Marketed Drug Clinical Insight

13. Diabetic Gastroparesis Drug Clinical Pipeline by Company & Phase
13.1 Preclinical to till Phase-III
13.2 Marketed Drug Clinical Insight

14. Diabetic Retinopathy Drug Clinical Pipeline by Company & Phase
14.1 Research to till Phase-III

15. Prediabetic State Drug Clinical Pipeline by Company & Phase
15.1 Phase-II

16. Diabetes Drug Clinical Pipeline by Company & Phase
16.1 Research to till Registered
16.2 Marketed Drug Clinical Insight

17. Competitive Landscape
17.1 AstraZeneca
17.2 Boehringer Ingelheim
17.3 Eli Lily
17.4 GalaxoSmithKline
17.5 Johnson & Johnson
17.6 MannKind Corporation
17.7 Merck
17.8 Novartis
17.9 Pfizer
17.10 Sanofi

Figure 1-1: Types of Diabetes
Figure 1-2: Diseases Associated with Diabetes
Figure 1-3: Diabetes Causing Factors
Figure 2-1: Function of Insulin
Figure 2-2: Mechanism of Metformin
Figure 2-3: Mechanism of Pramlintide
Figure 2-4: Mechanism of Sulphonylureas
Figure 2-5:Mechanism of Alpha-Glycosidase Inhibitors
Figure 2-6:Mechanism of Thiazolidinediones
Figure 3-1: Global Diabetes Incidences (Million), 2014 & 2035
Figure 3-2:Global Distribution of Diabetes Patients (Million), 2014
Figure 3-3: Diabetec Neuropathies Pipeline by Phase(%), 2015
Figure 3-4: Diabetec Neuropathies Pipeline by Phase(Number), 2015
Figure 3-5: Diabetic Nephropathies Pipeline by Phase(%), 2015
Figure 3-6: Diabetic Nephropathies Pipeline by Phase(Number), 2015
Figure 3-7: Diabetes Mellitus Pipeline by Phase(%), 2015
Figure 3-8: Diabetes Mellitus Pipeline by Phase(Number), 2015
Figure 3-9: Type 1 Diabetes Mellitus Pipeline by Phase(%), 2015
Figure 3-10: Type 1 Diabetes Mellitus Pipeline by Phase(Number), 2015
Figure 3-11: Type 2 Diabetes Mellitus Pipeline by Phase(%), 2015
Figure 3-12: Type 2 Diabetes Mellitus Pipeline by Phase(Number), 2015
Figure 3-13: Diabetic Foot Ulcer Pipeline by Phase(%), 2015
Figure 3-14: Diabetic Foot Ulcer Pipeline by Phase(Number), 2015
Figure 3-15: Diabetic Macular Oedema Pipeline by Phase(%), 2015
Figure 3-16: Diabetic Macular Oedema Pipeline by Phase(Number), 2015
Figure 3-17: Diabetic Gastroparesis Pipeline by Phase(%), 2015
Figure 3-18: Diabetic Gastroparesis Pipeline by Phase(Number), 2015
Figure 3-19: Diabetic Retinopathy Pipeline by Phase(%), 2015
Figure 3-20: Diabetic Retinopathy Pipeline by Phase(Number), 2015
Figure 3-21: Diabetes Insipidus Pipeline by Phase(%), 2015
Figure 3-22: Diabetes Insipidus Pipeline by Phase(Number), 2015
Figure 3-23: Multiple Diabetic Pipeline by Phase(%), 2015
Figure 3-24: Multiple Diabetic Pipeline by Phase(Number), 2015
Figure 4-1: Global Diabetes Drug Market Favorable Parameters

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India
+91-11-47067990

This release was published on openPR.